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BASIC RESEARCH ARTICLE
No gene-by-environment interaction of BDNF Val66Met polymorphism and
childhood maltreatment on anxiety sensitivity in a mixed race adolescent
sample
Lindi Martina, Sian Megan Joanna Hemmingsa, Martin Kiddb and Soraya Seedata
aDepartment of Psychiatry, Stellenbosch University, Cape Town, South Africa; bDepartment of Statistics and Actuarial Science,
Stellenbosch University, Cape Town, South Africa
ABSTRACT
Background: Anxiety disorders in youth are attributable to multiple causal mechanisms,
comprising biological vulnerabilities, such as genetics and temperament, and unfavourable
environmental influences, such as childhood maltreatment (CM).
Objective: A gene-environment (G x E) interaction study was conducted to determine the
interactive effect of the BDNF Val66Met polymorphism and CM to increase susceptibility to
anxiety sensitivity (AS) in a sample of mixed race adolescents.
Method: Participants (n = 308, mean age = 15.8 years) who were all secondary school
students and who completed measures for AS and CM were genotyped for the BDNF
Val66Met polymorphism. Hierarchical multiple regression analysis was conducted to assess
G x E influences on AS. Age and gender were included in the models as covariates as age
was significantly associated with AS total score (p < .05), and females had significantly
higher AS scores than males (p < .05).
Results: A main effect of CM on AS was evident (p < .05), however, no main effect of BDNF
genotype on ASwas observed (p > .05). A non-significant G x E effect on ASwas revealed (p < .05).
Conclusions: Our results suggest that CM does not have a moderating role in the relation-
ship between the BDNF Val66Met genotype and the increased risk of anxiety-related
phenotypes, such as AS. Given the exploratory nature of this study, findings require
replication in larger samples and adjustment for population stratification to further explore
the role of BDNF Val66Met and CM on AS in mixed race adolescents.
Ausencia de interacciôn gen-entorno del polimorfismo val66met del
bdnf y el maltrato infantil sobre la sensibilidad a la ansiedad en una
muestra de adolescentes de raza mixta
Antecedentes: los trastornos de ansiedad en los jóvenes son atribuibles a múltiples meca-
nismos causales, que comprenden vulnerabilidades biológicas, como la genética y el tem-
peramento; y las influencias ambientales desfavorables, como el maltrato infantil (MI).
Objetivo: Se realizó un estudio interacción gen-ambiente (GxA) para determinar el efecto
interactivo del polimorfismo Val66Met del BDNF y MI para aumentar la susceptibilidad para
la sensibilidad a la ansiedad (SA) en una muestra de adolescentes de raza mixta.
Método: los participantes (n=308, Edad Media:15.8 años) que fueron todos estudiantes de
secundaria que completaron las medidas para SA y MI, fueron genotipificados para el polimor-
fismo Val66Met del BDNF. Se realizó un análisis de regresión múltiple jerárquica para evaluar las
influencias GxA en SA. La edad y género se incluyeron como covariables en los modelos, ya que
la edad se asoció significativamente con el puntuación total SA (p<0.05), y las mujeres tuvieron
puntuaciones de SA significativamente mayores que los hombres (p<0.05).
Resultados: Un efecto principal de MI en SA fue evidente (p<0.05), sin embargo, no se
observó ningún efecto principal del genotipo BDNF en SA (p>0.05). Se reveló un efecto GxA
No significativo sobre SA (p<0.05).
Conclusiones: Nuestros resultados sugieren que MI no tiene un rol moderador en la relación
entre el genotipo Val66Met del BDNF y el mayor riesgo de fenotipos relacionados con la
ansiedad, como SA. Dada la naturaleza exploratoria de este estudio, los hallazgos requieren la
replicación en muestras más grandes y el ajuste de la estratificación de la población para
explorar más a fondo el rol de Val66Met del BDNF y MI en SA en adolescentes de raza mixta.
青少年混合种族样本中BDNF Val66Met多态性与童年虐待对焦虑敏感性
没有发现基因 - 环境相互作用
背景：青年时期的焦虑症可归因于多种因果机制，包括生物学上的易感性（如遗传和气
质）; 和不利的环境影响，如童年虐待（CM）。
目的：分析基因-环境（G×E）相互作用研究以确定BDNF Val66Met多态性与CM在混合种
族青少年样本中增加对焦虑敏感性（AS）的易感性的交互作用。
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HIGHLIGHTS
• We assessed the interactive
effect of the BDNF Val66Met
polymorphism and
childhood maltreatment on
anxiety sensitivity in
adolescents.
• A main effect of childhood
maltreatment on anxiety
sensitivity was evident,
however, no main effect of
BDNF genotype on anxiety
sensitivity was revealed.
• No significant G x E (BDNF
Val66Met by childhood
maltreatment) effect on
anxiety sensitivity was
evident.
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方法：被试（n = 308，平均年龄：15.8岁）都是中学生，并完成了AS和CM测量，进行了
BDNF Val66Met多态性的基因型分类。进行层级多元回归分析以评估G×E对AS的影响。 年
龄和性别作为协变量包括在模型中，因为年龄与AS总分显著相关（p <0.05），女性AS评
分显著高于男性（p <0.05）。
结果：CM对AS有明显主效应（p <0.05），但BDNF基因型对AS的主效应没有观察到（p>
0.05）， 说明了GxE对 AS的影响不显著（p <0.05）。
结论：我们的研究结果表明，CM没有调节BDNF Val66Met基因型与焦虑相关表型（如AS）
风险增加之间的关系。鉴于本研究的探索性质，研究结果需要在更大的样本中重复，并调
整人群分层，以进一步探索在青少年混合种族样本中BDNF Val66Met和CM对AS的作用。
1. Background
Anxiety disorders in youth are attributable to multiple
causal mechanisms, comprising biological vulnerabil-
ities, such as genetics and temperament, and unfavour-
able environmental influences (Broekman, 2011;
Dabkowska & Dabkowska-Mika; Keeley & Storch,
2009; Weems & Stickle, 2005), such as childhood mal-
treatment (CM) and trauma (Al-Hadethe, Hunt,
Thomas, & Al-Qaysi, 2014; Dvir, Ford, Hill, & Frazier,
2014; Nordanger et al., 2014). Temperament or disposi-
tional characteristics may be considered intermediate
phenotypes for psychiatric disorders, reflecting sub-
threshold clinical presentations (Altınbaş et al., 2015).
Anxiety-related temperamental traits, such as anxiety
sensitivity (AS) and trait anxiety (Eysenck, 1992; Reiss,
Peterson, Gursky, & McNally, 1986), have consistently
been found to be predictive of anxiety disorders and
symptoms in youth (McLaughlin, Stewart, & Taylor,
2007; Muris, Schmidt, Merckelbach, & Schouten,
2001; Schmidt, Zvolensky, & Maner, 2006; Schmidt
et al., 2010; Weems et al., 2007), particularly panic
disorder symptoms (Hayward, Killen, Kraemer, &
Taylor, 2000; Schmidt et al., 2006). Such temperamental
traits are considered developmentally stable risk factors
for anxiety (Garcia et al., 2013; Zavos, Gregory, & Eley,
2012; Zavos, Rijsdijk, & Eley, 2012).
AS refers to fear of anxiety-related or arousal-related
sensations and symptoms (Reiss & McNally, 1985) due
to erroneous or dysfunctional beliefs about the conse-
quences of such symptoms (Reiss et al., 1986).
Individuals with elevated levels of anxiety-related tem-
peramental traits, such as those with high levels of AS,
may be termed ‘anxiety prone’, relative to those indivi-
duals with normative levels of anxiety (Simmons,
Strigo, Matthews, Paulus, & Stein, 2006).
AS is moderately heritable, in the range 34–45%
in youth and adults (Eley, Gregory, Clark, & Ehlers,
2007; Stein, Jang, & Livesley, 1999; Zavos, Rijsdijk,
Gregory, & Eley, 2010). Moreover, AS is thought to
be interactively impacted by additive genetic factors
as well as unique environmental factors (Garcia
et al., 2013; Stein et al., 1999), such as stressful
life events (Aktekin et al., 2001; Zavos et al.,
2012), including CM and severe family conflict
(McLaughlin & Hatzenbuehler, 2009; Scher &
Stein, 2003), demonstrating the interactive effect of
genes and environment on AS.
Brain-derived neurotrophic factor (BDNF) is a
secretory protein in the neurotrophin family known
to influence the proliferation, survival, differentiation,
repair and regulation of synaptic plasticity of neuro-
nal cells in the developing and adult brain (Bath &
Lee, 2006; Chen et al., 2006; Martinowich, Manji, &
Lu, 2007; Notaras, Hill, & van den Buuse, 2015).
BDNF is widely expressed in the hippocampus and
cerebral cortex (Hofer, Pagliusi, Hohn, Leibrock, &
Barde, 1990; Huang & Reichardt, 2001) and enhances
hippocampal long-term potentiation (Figurov, Pozzo-
Miller, Olafsson, Wang, & Lu, 1996) associated with
both memory and learning efficiency (Hariri et al.,
2003; Yamada, Mizuno, & Nabeshima, 2002). The
gene encoding BDNF contains a functional single-
nucleotide polymorphism (SNP) resulting in a valine
(val) to methionine (met) substitution at amino acid
66 (Val66Met, rs6265) in the 5ʹ pro-BDNF domain
(Egan et al., 2003). Compared with the Val66 allele,
the Met66 allele is associated with a decrease in activ-
ity-dependent secretion of BDNF (Egan et al., 2003).
BDNF has received attention due to its evident role in
anxiety and mood disorders (Angelucci et al., 2014;
Hemmings et al., 2008; Li, Chang, & Xiao, 2016;
Martinowich et al., 2007; Molendijk et al., 2014;
Suliman, Hemmings, & Seedat, 2013), although find-
ings have been inconsistent across studies (Frustaci,
Pozzi, Gianfagna, Manzoli, & Boccia, 2008; Hong,
Liou, & Tsai, 2012; Lam, Cheng, Hong, & Tsai,
2004; Minelli et al., 2011; Notaras et al., 2015;
Surtees et al., 2007; Wang et al., 2015).
Some studies have reported associations between the
BDNF Val66Met polymorphism and personality traits
such as trait anxiety and neuroticism (Lang et al., 2005;
Sen et al., 2003), while others have not (Terracciano et al.,
2010; Willis-Owen et al., 2005). Previous studies have
found associations between the Met66 allele and
increased introversion (Terracciano et al., 2010), harm
avoidance (Montag, Basten, Stelzel, Fiebach, & Reuter,
2010), tendency to ruminate (Beevers,Wells, &McGeary,
2009), lower levels of conscientiousness (Hiio et al., 2011),
an increased vulnerability to stress (Casey et al., 2009),
increased anxiety-related behaviours (Chen et al., 2006)
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and increased risk of an anxiety disorder in children and
adolescents (Tocchetto et al., 2011). In contrast, other
studies have reported an association between the Val66
allele and higher neuroticism scores, as well as increased
risk of anxiety symptoms during adolescence (Chen, Yu,
Liu, Zhang, & Zhang, 2015; Frustaci et al., 2008).
Studies have demonstrated that acute and
chronic stress (e.g. military training, psychological
job stress, acute and repeated restraint in animals)
are associated with decreased BDNF (Mitoma et al.,
2008; Murakami, Imbe, Morikawa, Kubo, & Senba,
2005; Suzuki et al., 2014) and enhancement of
anxiety-related behaviours (Chen et al., 2006). In
adults with lifetime major depressive disorder, for
example, a linear relationship between exposure to
CM (i.e. emotional neglect, psychological abuse,
sexual abuse) and reduced BDNF serum levels has
been demonstrated in Met66 allele carriers, with
the lowest BDNF levels evident in Met66 carriers
reporting two or more childhood trauma types
(Elzinga et al., 2011). Similarly, compared with
non-trauma exposed children and adolescents,
youth with CM histories (i.e. sexual abuse) have
been found to exhibit significantly lower serum
BDNF levels, with the lowest levels documented
in those with multiple sexual assault histories
(Şimşek, Yüksel, Kaplan, Uysal, & Alaca, 2015).
There is support for the role of gene-environment
interaction in the aetiology of youth and adult anxi-
ety, including panic and separation anxiety, anxiety
symptoms, anxious mood and anxious temperament
(Baumann et al., 2013; Chen et al., 2015; Gunthert
et al., 2007; Ibarra et al., 2014; Klauke et al., 2011;
Lau, Gregory, Goldwin, Pine, & Eley, 2007; Stein,
Schork, & Gelernter, 2008; Vendlinski, Lemery-
Chalfant, Essex, & Goldsmith, 2011). CM and AS
have both consistently been implicated as risk factors
for psychopathology, including anxiety disorders
(Collishaw et al., 2007; Kessler, McLaughlin et al.,
2010; McLaughlin et al., 2007, 2012). We have pre-
viously determined, in a sample of secondary school-
attending adolescents, that CM is significantly and
positively associated with anxiety-related tempera-
mental traits such as AS and trait anxiety (Martin,
Viljoen, Kidd, & Seedat, 2014). Further, there is evi-
dence that interactions of life stress/early adversity
(including abuse and neglect) with BDNF Val66Met
gene variants predict subsequent risk for psycho-
pathology, such as depression, in youth and adults
(Carver, Johnson, Joormann, Lemoult, & Cuccaro,
2011; Chen, Li, & McGue, 2013; Gutiérrez et al.,
2015; Hosang, Shiles, Tansey, McGuffin, & Uher,
2014). G x E interactions (i.e. BDNF Val66Met and
early life stress exposure) have previously been found
to be associated with abnormalities in brain struc-
tures, physiological indicators, deficits in cognition
(i.e. poorer working memory), higher levels of
depression and anxiety, and elevated temperamental
traits (Gatt et al., 2009). However, data on the inter-
active effects of CM and genetic factors, such as the
BDNF Val66Met polymorphism, on susceptibility to
anxiety-related temperamental traits, such as AS, in
adolescents is limited. Identifying risk markers for
AS, an intermediate phenotype for anxiety disorders,
in non-clinical samples is crucial to informing com-
munity- and school-level prevention strategies. Early
and accurate identification is even more important in
light of the wide mental health treatment gap that
exists in many country settings. To our knowledge,
no previous studies have investigated whether the
BDNF Val66Met polymorphism interacts with CM
to increase susceptibility to AS in adolescents. In
addition, relative to studies that have assessed the
BDNF Val66Met polymorphism in Caucasian sam-
ples, there is limited information of the allelic distri-
bution of the BDNF Val66Met polymorphism in
ethnically diverse samples. A G x E interaction
study was conducted to determine the interactive
effect of the BDNF Val66Met polymorphism and
CM to increase susceptibility to AS in a school sam-
ple of South African mixed race adolescents.
2. Method
2.1. Design
This study was a two-tier study in a sample of secondary
school students. Tier 1 employed stratified two-stage
cluster sampling in which public secondary schools in
Cape Town, South Africa, and students within these
schools, were randomly selected. The Tier 1 sample of
secondary school students was therefore representative
of students attending public secondary schools in Cape
Town, South Africa. Tier 1 allowed for the screening (e.g.
of levels of CM and AS) and collection of salivary DNA
from secondary school students from 29 public schools
in Cape Town, South Africa. A description of Tier 1
methods, including clinical data pertaining to Tier 1,
has previously been reported (Martin et al., 2014). Four
groups of adolescents grouped according to levels of Tier
1 self-reported CM and AS, amongst others, and
matched as closely as possible on age, ethnicity, gender
and educational status, were included in the second tier
of the study and underwent a neuropsychological and
neuroimaging assessment, amongst others.
2.2. Participants
The Tier 1 sample consisted of 1149 secondary
school students. DNA was extracted from 985 par-
ticipants (i.e. comprising 85.7% of the total Tier 1
sample) at the same time that Tier 1 self-report
measures (e.g. CM and AS) were administered.
The majority of the Tier 1 sample consisted of
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Black (64.4%) and mixed race (32.2%) participants.
As almost all Black participants (99.68%, 628/630)
in the sample were Val66Val genotype carriers, the
subset reported on here included only those parti-
cipants that self-classified as ‘mixed race’ and for
whom BDNF data were available (n = 308).
This study was approved by the Health Research
Ethics Committee of Stellenbosch University, South
Africa (ethics reference number: N10/11/370), and
permission to access secondary schools and con-
duct this study was provided by the Western Cape
Education Department. Written informed consent
was obtained from parents/legal guardians and
written assent was obtained from the students
themselves.
2.3. Self-report measures
The following self-report questionnaires, amongst
others, were administered at the secondary schools
on a single occasion.
The Childhood Anxiety Sensitivity Index (CASI;
Silverman, Fleisig, Rabian, & Peterson, 1991) is an
18-item instrument that measures the fear of anxiety
symptoms, designed for use with school-age children
and adolescents. The CASI yields a total score that
can range from 18 to 54, with higher scores reflecting
higher levels of AS.
The Childhood Trauma Questionnaire – Short
Form (CTQ-SF; Bernstein et al., 2003) is a brief, 28-
item, retrospective self-report measure of the fre-
quency of abuse (i.e. emotional, physical, sexual)
and neglect (i.e. emotional, physical) experienced
prior to age 18 years. The CTQ-SF yields a total
score in the range 25–125, with higher scores reflect-
ing more severe levels of abuse or neglect. Scores for
each of the CTQ-SF subscales are in the range 5–25,
with higher scores indicating more severe childhood
trauma (Bernstein & Fink, 1998). For the purpose of
the current study, we enquired about abuse and
neglect experienced prior to age 12 years.
2.4. Genotyping
Genomic DNA was extracted from saliva collected in
Oragene DNA self-collection kits (OG-500, DNA
Genotek, Ontario, Canada) using the Prep-It L2P
reagent (DNA Genotek) as per manufacturer’s
instructions. The BDNF Val66Met polymorphism
(rs6265) was genotyped as previously described
(Hemmings et al., 2008).
2.5. Data analysis
All analyses were conducted using STATISTICA
version 13 (StatSoftInc., 2015). Univariate normal-
ity was determined for all demographic and clinical
variables. Demographic characteristics of the total
sample (i.e. age, gender, current grade at school), as
well as self-report variables of interest (i.e. AS,
CTQ), were calculated as means (M) and standard
deviations (SD) for quantitative variables and
counts and associated percentages for categorical
variables (e.g. gender). The severity (i.e. minimal,
moderate, severe, extreme) of abuse and neglect
categories of the CTQ (i.e. emotional, physical
and sexual abuse, emotional and physical neglect)
were computed for the total sample using recom-
mended cut-off scores (Bernstein & Fink, 1998).
To determine if AS levels differed by gender and
age, t-tests and Pearson’s correlation statistic, respec-
tively, were employed. Genotype counts (%) and the
Hardy-Weinberg equilibrium (HWE) p-value was
determined using the R Package SNPassoc
(González et al., 2007). Demographic and clinical
characteristics of the sample by genotype (i.e. Val66
homozygotes and Met66 allele carriers) were sum-
marized as means (M) and standard deviations (SD)
for quantitative variables, and counts were used for
categorical variables. Independent samples t-tests and
chi-square tests were used to determine any group
(i.e. genotype) differences for the quantitative and
categorical variables, respectively. Pearson’s correla-
tion statistic was used to assess the relationship
between CTQ total score and CASI total score by
genotype.
Hierarchical multiple regression analysis was used
to assess the effects of BDNF genotype (coded 0 for
Val66Val and 1 for Met66 allele carriers), level of CM
and the interaction of BDNF genotype and CM, on
AS. In the first model, gender, age, BDNF genotype
and CTQ total score were included to assess the main
effects of BDNF genotype and CTQ total score on the
outcome, AS. In the second model, the two-way
interaction term (i.e. BDNF x CTQ) was added. The
F-to-remove test was used to compare the R2 change
between the first and second model to determine
whether the inclusion of the interaction term resulted
in a significant increase in explained variance.
3. Results
3.1. Demographic and clinical variables
All participants were secondary school students
(mean: grade 10; range: grades 8–10). The mean age
of the sample was 15.8 years (SD = 1.59; range: 12–
20 years). Over half the sample was female (183/
308, 59.4%).
The mean CASI score for the total sample was
34.10 (SD = 6.81, range: 18–53). The mean CTQ
score for the total sample was 43.73 (SD = 14.54,
range: 25–96). Mean scores for the CTQ subscales
for the total sample were as follows: emotional
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abuse: M = 10.54 (SD = 4.78), physical abuse:
M = 7.58 (SD = 4.01), sexual abuse: M = 7.04
(SD = 4.09), emotional neglect: M = 10.61
(SD = 4.46), physical neglect: M = 7.96 (SD = 3.34)
(see Table 1 for frequencies and percentages of abuse
and neglect types endorsed by the sample). Emotional
abuse was the most frequently reported CM type (i.e.
57.4% of the sample reportedly experienced low to
extreme forms of emotional abuse), followed by emo-
tional neglect (i.e. 49.9% of the sample reportedly
experienced low to extreme forms) and physical
neglect (i.e. 43.8% low to extreme forms). Age was
significantly associated with AS (r = 0.17, p < .05),
and females had significantly higher AS scores than
males [males: M = 31.58, SD = 6.26; females:
M = 35.83, SD = 6.64, (t(306) = −5.63, p < .05)].
3.2. Genetic variables
The BDNF Val66Met SNP was in Hardy-Weinberg
equilibrium (p = .456). The following genotype fre-
quencies were evident in our mixed race sample:
Val66Val (75.65%, 233/308), Val66Met (22.08%, 68/
308) and Met66Met (2.3%, 7/308). These frequencies
are generally in line with those determined in
Caucasian samples (Carver et al., 2011; Gatt et al.,
2009; Pivac et al., 2009; Surtees et al., 2007; Zeni et al.,
2013) and in South African mixed race samples
(Dalvie et al., 2014), and confirm the low rates of
Met66 allele carriers evident in ethnic groups in sub-
Saharan Africa (Petryshen et al., 2009). Given the low
frequency of Met66Met genotype carriers, Val66Met
and Met66Met genotypes were combined (24.35%,
75/308) for genotypic analyses to increase statistical
power. No significant differences in either demo-
graphic [i.e. age and grade at school (p > .05)] or
self-report measures [i.e. CASI and CTQ (p > .05)],
by genotype, were evident. No association between
gender and genotype was evident [Χ2 (1, N
= 308) = 0.480, p > .05]. The relationship between
CTQ and CASI was relatively stronger in Met66 allele
carriers (r = 0.48, p < .01) than in Val66 homozygotes
(r = 0.32, p < .01) (see Table 2 for demographic and
self-report variables by genotype).
Results of multiple regression analyses (i.e. model 1
and model 2) are presented in Table 3. A significant
main effect of CTQ total score (p < .01) on AS was
evident, however, no significant main effect of BDNF
genotype on AS was observed (p > .05). In the second
model, the inclusion of the interaction term did not
contribute to an increase in explained variance (p > .05).
4. Discussion
Anxiety-related temperamental traits, such as AS,
trait anxiety and neuroticism, are said to be interac-
tively impacted by genetic and environmental factors,
such as CM and early life stress and trauma. This
study investigated whether the BDNF Val66Met poly-
morphism interacted with CM to increase suscept-
ibility to AS in a sample of mixed race adolescents.
To our knowledge, this is the first study to assess the
role of BDNF Val66Met in AS in a South African
mixed race sample of adolescents.
Our results revealed a significant main effect of CM
on AS, however, there was no significant main effect of
BDNF genotype on AS. These findings suggest that the
BDNF Val66Met polymorphism does not have a direct
effect on AS. This finding is in line with studies that
have found no significant direct association between
BDNF Val66Met polymorphism and personality traits
such as neuroticism or harm avoidance and anxiety
disorders or mood disorders, including OCD, panic
disorder, PTSD and depression (Arias et al., 2012;
Chen et al., 2013; Frustaci et al., 2008; Hong et al.,
2012; Minelli et al., 2011; Surtees et al., 2007;
Terracciano et al., 2010), despite some studies reporting
such associations (Frustaci et al., 2008; Lang et al., 2005;
Min et al., 2013; Montag et al., 2010; Sen et al., 2003;
Terracciano et al., 2010). Firstly, the grouping ofMet66
allele carriers (i.e.Met66Met and Val66Met genotypes),
as is frequently carried out in studies in which the rate
of the Met66Met genotype is relatively low, such as in
Caucasian samples (Gatt et al., 2009; Lehto, Maestu,
Kiive, Veidebaum, & Harro, 2016; Nedic et al., 2013;
Pivac et al., 2009), may introduce a bias in which a main
effect of genotype is not detected due to the exclusion of
Table 1. Frequencies and percentages of abuse and neglect categories in the total sample (n = 308).
Childhood trauma category None or minimal Low to moderate Moderate to severe Severe to extreme
Emotional abuse 131 (42.5%) 87 (28.2%) 44 (14.3%) 46 (14.9%)
Physical abuse 211 (68.5%) 42 (13.6%) 23 (7.5%) 32 (10.4%)
Sexual abuse 202 (65.6%) 36 (11.7%) 39 (12.7%) 31 (10.1%)
Emotional neglect 154 (50%) 90 (29.2%) 38 (12.3%) 26 (8.4%)
Physical neglect 173 (56.2%) 61 (19.8%) 38 (12.3%) 36 (11.7%)
Table 2. Summary statistics for demographic and clinical
variables by BDNF genotype.
Genotype
Val66Val (N = 233) Met66Met + Val66Met (N = 75)
Variable Mean (SD) Mean (SD)
p-
value
Age 15.83 (1.56) 15.79 (1.71) > .05
Grade 9.86 (1.31) 9.98 (1.36) > .05
CASI 34.22 (6.75) 33.73 (7.01) > .05
CTQ 44.18 (14.78) 42.36 (13.78) > .05
CASI = Childhood Anxiety Sensitivity Index; CTQ = Childhood Trauma
Questionnaire
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the Met66Met genotype in analyses (Notaras et al.,
2015). Secondly, the Val66Met and Met66Met geno-
types, respectively, may have dissimilar effects (Hong
et al., 2012). Nevertheless, the main effect of CM on AS
determined in this study provides support for the posi-
tive association between CM, including stressful life
events, and AS in adolescents (McLaughlin &
Hatzenbuehler, 2009; Tollenaar, Molendijk, Penninx,
Milaneschi, & Antypa, 2017), a well-established cogni-
tive risk factor for the development of anxiety disorders
and associated symptoms in youth (Hishinuma et al.,
2001; McLaughlin et al., 2007; Muris et al., 2001).
Furthermore, our finding adds to the well-established
literature demonstrating the adverse acute and long-
term effects of CM or trauma on mental health and
cognition in youth and adults (De Bellis, Woolley, &
Hooper, 2013; Greger, Myhre, Lydersen, & Jozefiak,
2015; Irigaray et al., 2013; Taillieu, Brownridge,
Sareen, & Afifi, 2016; Teicher, Ohashi, Lowen, Polcari,
& Fitzmaurice, 2015).
Our results revealed a non-significant BDNF geno-
type x CM effect on AS. This finding is not consistent
with studies that found that the low-functioning BDNF
Met66 allele and CM/childhood trauma or early life
adversity or stress interact to predict increased suscept-
ibility for psychopathology, including anxiety-related
temperamental traits, such as neuroticism (Gatt et al.,
2009) and guilt-proneness (Szentágotai-Tətar et al.,
2015), anxiety symptoms (Gatt et al., 2009) and mood
disorders and associated symptoms (Aguilera et al., 2009;
Carver et al., 2011; Gutiérrez et al., 2015). Our findings
are also not in agreement with G x E studies that found
an interactive effect of the higher functioningVal66 allele
and environmental exposures (i.e. adversity, negative
stressors, recent life events) on psychopathology, such
as increased levels of neuroticism, harm avoidance and
depression (Chen et al., 2013; Kim et al., 2009; Lehto
et al., 2016). Apart from the possible confounding effects
of age and gender, discrepant results across studies may
in part be due to population-driven differences in BDNF
Val66Met frequencies, given that the Met66 allele has
consistently been found to be more common in Asian
populations than in Caucasian populations (Chen et al.,
2013; Petryshen et al., 2009). A further confounding
factor may include phenotype heterogeneity and metho-
dological (assessment) differences (Hong et al., 2012).
A number of study limitations should be taken into
account in interpreting the current findings. First, due
to the cross-sectional nature of this study, inferences
about causality cannot be made. Second, our sample
size of N = 308 is relatively small given the estimated
sample sizes required in candidate gene studies in which
functional polymorphisms are assessed and in which
minor effects are expected (Duncan & Keller, 2011).
Third, use of the CTQ, a retrospective self-report mea-
sure of CM, may have introduced recall bias which may
have resulted in the over- or under-reporting of mal-
treatment frequency. Fourth, we explored one poly-
morphism within the BDNF gene. Finally, we did not
correct for gene-environment correlation (rGEs) or
population stratification. The South African mixed
race population is characterized by high levels of admix-
ture (Tishkoff et al., 2009) and ancestral diversity (i.e.
Khoesan, European and Asian ethnicity) (Hemmings
et al., 2016; Wright, Niehaus, Koen, Drögemöller, &
Warnich, 2011), suggestive of genetic heterogeneity,
which may have influenced our results. Findings of
this exploratory study are therefore preliminary. Our
findings add to the literature on aetiological processes
that may underlie the development of anxiety-related
traits, symptoms and disorder in adolescents. More
specifically, our findings shed light on the role of the
BDNF Val66Met polymorphism in the development of
anxiety-related traits in mixed race adolescents in the
context of childhood adversity. Furthermore, these
results extend findings of the role of BDNF and CM
on AS. Previous studies have focused on convenience
samples of college students, or adults, and predomi-
nantly on the effects of the 5-HTTLPR polymorphism
(Hemmings et al., 2016; Kim et al., 2009; Klauke et al.,
2011; Laucht et al., 2009; Stein et al., 2008). Our results
suggest that the influence of CM on adolescent AS levels
is not moderated by the BDNF Val66Met polymorph-
ism. Our findings highlight the importance of assessing
gene-environment interactions in the assessment of
genetic effects on anxiety-related phenotypes associated
with anxiety disorders. Recommendations for future
research include replication in larger samples of mixed
Table 3. Regression analysis depicting main and interaction effects.
Model Predictors ß t (p) R R2 ΔR2 ΔF (p)
1 Gender 0.29 5.83* 0.488 0.239
Age 0.15 2.93*
BDNF Met66 0.00 0.01
CTQ total 0.34 6.82*
2 Gender 0.30 5.76* 0.493 0.243 0.004 1.739 (> .05)
Age 0.15 2.91*
BDNF Met66 −0.20 −1.25
CTQ total 0.31 5.44*
BDNF Met66 x CTQ total 0.21 1.32
BDNF Met66 = BDNF Met66 allele carriers vs. BDNF Val66 homozygotes; ß = standardized regression coefficient;
t (p) = t-statistic and associated p-value; *p < .05; R = correlation statistic; R2 = explained variance.
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race participants in which population stratification is
corrected for and in which the Met66Met genotype is
better represented (Notaras et al., 2015). Furthermore,
variation across the BDNF gene would be useful to
consider (Mandelman & Grigorenko, 2012).
Additionally, the effect of other genetic variants, in
conjunction with the BDNF Val66Met polymorphism,
should be explored given findings of an epistatic effect
between BDNF and the serotonin transporter genes
(Martinowich & Lu, 2008; Pezawas et al., 2008).
Further support for the aforementioned is reflected in
findings of gene x gene and gene x gene x environment
interactions which are indicative of significant interac-
tion effects of the BDNF Val66Met polymorphism and
the serotonin transporter gene (SLC6A4) on anxiety-
related traits (e.g. neuroticism and harm avoidance)
(Arias et al., 2012; Terracciano et al., 2010) and depres-
sive symptoms and disorder (Gutiérrez et al., 2015;
Kaufman et al., 2006). Finally, the effects of environ-
mental influences other than CM, such as parenting
rearing practices (Ibarra et al., 2014) and general self-
efficacy (Schiele et al., 2016), on AS should be explored.
Investigation of the aforementioned would provide a
clearer understanding of the genetic and environmental
impacts on AS in mixed race adolescent samples.
Acknowledgments
The authors would like to thank all the adolescents for
their participation in this study.
Funding
This work was supported by the South African Research
Chairs Initiative (SARChI) in PTSD, hosted by
Stellenbosch University, funded by the Department of
Science and Technology (DST) and administered by the
National Research Foundation (NRF) under Grant number
64811; and the Hendrik Vrouwes Research Scholarship
Program and the Ithemba Foundation.
References
Aguilera, M., Arias, B., Wichers, M., Barrantes-Vidal, N.,
Moya, J., Villa, H., . . . Fañanás, L. (2009). Early adver-
sity and 5-HTT/BDNF genes: New evidence of gene-
environment interactions on depressive symptoms in a
general population. Psychological Medicine, 39(9),
1425–1432.
Aktekin, M., Karaman, T., Senol, Y. Y., Erdem, S., Erengin,
H., & Akaydin, M. (2001). Anxiety, depression and
stressful life events among medical students: A prospec-
tive study in Antalya, Turkey. Medical Education, 35,
12–17.
Al-Hadethe, A., Hunt, N., Thomas, S., & Al-Qaysi, A.
(2014). Prevalence of traumatic events and PTSD symp-
toms among secondary school students in Baghdad.
European Journal of Psychotraumatology, 5, 1–5.
Altınbaş, G., Altınbaş, K., Gülöksüz, S. A., Gülöksüz, S.,
Aydemir, Ö., & Özgen, G. (2015). Temperament
characteristics in patients with panic disorder and their
first-degree relatives. Comprehensive Psychiatry.
doi:10.1016/j.comppsych.2015.03.008
Angelucci, F., Ricci, V., Gelfo, F., Martinotti, G., Brunetti,
M., Sepede, G., . . . Caltagirone, C. (2014). BDNF serum
levels in subjects developing or not post-traumatic stress
disorder after trauma exposure. Brain and Cognition, 84
(1), 118–122.
Arias, B., Aguilera, M., Moya, J., Sáiz, P. A., Villa, H.,
Ibáñez, M. I., . . . Fañanás, L. (2012). The role of genetic
variability in the SLC6A4, BDNF and GABRA6 genes in
anxiety-related traits. Acta Psychiatrica Scandinavica,
125(3), 194–202.
Bath, K. G., & Lee, F. S. (2006). Variant BDNF (Val66Met)
impact on brain structure and function. Cognitive,
Affective & Behavioral Neuroscience, 6(1), 79–85.
Retrieved from http://www.pubmedcentral.nih.gov/arti
clerender.fcgi?artid=2735856&tool=pmcentrez&render
type=abstract
Baumann, C., Klauke, B., Weber, H., Domschke, K.,
Zwanzger, P., Pauli, P., . . . Reif, A. (2013). The interac-
tion of early life experiences with COMT val158met
affects anxiety sensitivity. Genes, Brain, and Behavior,
12(8), 821–829.
Beevers, C. G., Wells, T. T., & McGeary, J. E. (2009). The
BDNF Val66Met polymorphism is associated with rumi-
nation in healthy adults. Emotion, 9(4), 579–584.
Bernstein, D., & Fink, L. (1998). Childhood trauma ques-
tionnaire: A retrospective self-report manual. San
Antonio, TX: The Psychological Corporation.
Bernstein, D. P., Stein, J. A., Newcomb, M. D., Walker, E.,
Pogge, D., Ahluvalia, T., . . . Zule, W. (2003).
Development and validation of a brief screening version
of the childhood trauma questionnaire. Child Abuse &
Neglect, 27(2), 169–190.
Broekman, B. F. P. (2011). Stress, vulnerability and resili-
ence, a developmental approach. European Journal of
Psychotraumatology, 2, 7229.
Carver, C. S., Johnson, S. L., Joormann, J., Lemoult, J., &
Cuccaro, M. L. (2011). Childhood adversity interacts
separately with 5-HTTLPR and BDNF to predict lifetime
depression diagnosis. Journal of Affective Disorders, 132
(1–2), 89–93.
Casey, B. J., Glatt, C. E., Tottenham, N., Soliman, F., Bath, K.,
Amso, D., . . . Lee, F. S. (2009). Brain-derived neurotrophic
factor as a model system for examining gene by environ-
ment interactions across development. Neuroscience, 164
(1), 108–120.
Chen, J., Li, X., & McGue, M. (2013). The interacting effect
of the BDNF Val66Met polymorphism and stressful life
events on adolescent depression is not an artifact of
gene-environment correlation: Evidence from a longitu-
dinal twin study. Journal of Child Psychology and
Psychiatry and Allied Disciplines, 54(10), 1066–1073.
Chen, J., Yu, J., Liu, Y., Zhang, L., & Zhang, J. (2015).
BDNF Val66Met, stress, and positive mothering:
Differential susceptibility model of adolescent trait anxi-
ety. Journal of Anxiety Disorders, 34, 68–75.
Chen, Z.-Y., Jing, D., Bath, K. G., Ieraci, A., Khan, T., Siao,
C.-J., . . . Lee, F. S. (2006). Genetic variant BDNF
(Val66Met) polymorphism alters anxiety-related beha-
vior. Science, 314(5796), 140–143.
Collishaw, S., Pickles, A., Messer, J., Rutter, M., Shearer, C.,
& Maughan, B. (2007). Resilience to adult psychopathol-
ogy following childhood maltreatment: Evidence from a
community sample. Child Abuse & Neglect, 31(3), 211–
229.
EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY 7
Dalvie, S., Stein, D. J., Koenen, K., Cardenas, V., Cuzen, N.
L., Ramesar, R., . . . Brooks, S. J. (2014). The BDNF p.
Val66Met polymorphism, childhood trauma, and brain
volumes in adolescents with alcohol abuse. BMC
Psychiatry, 14(1), 1–8.
De Bellis, M. D., Woolley, D. P., & Hooper, S. R. (2013).
Neuropsychological findings in pediatric maltreatment:
Relationship of PTSD, dissociative symptoms, and
abuse/neglect indices to neurocognitive outcomes.
Child Maltreatment, 18(3), 171–183.
Duncan, L. E., & Keller, M. C. (2011). A critical review of
the first 10 years of candidate gene-by-environment
interaction research in psychiatry. American Journal of
Psychiatry, 168(10), 1041–1049.
Dvir, Y., Ford, J. D., Hill, M., & Frazier, J. A. (2014).
Childhood maltreatment, emotional dysregulation, and
psychiatric comorbidities. Harvard Review of Psychiatry,
22(3), 149–161.
Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E.,
Kolachana, B. S., Bertolino, A., . . . Weinberger, D. R.
(2003). The BDNF Val66Met polymorphism affects
activity-dependent secretion of BDNF and human mem-
ory and hippocampal function. Cell, 112(2), 257–269.
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/
12553913
Eley, T. C., Gregory, A. M., Clark, D. M., & Ehlers, A.
(2007). Feeling anxious: A twin study of panic/somatic
ratings, anxiety sensitivity and heartbeat perception in
children. Journal of Child Psychology and Psychiatry, 48
(12), 1184–1191.
Elzinga, B. M., Molendijk, M. L., Oude Voshaar, R. C., Bus, B.
A. A., Prickaerts, J., Spinhoven, P., & Penninx, B. J. W. H.
(2011). The impact of childhood abuse and recent stress on
serum brain-derived neurotrophic factor and the moderat-
ing role of BDNF Val 66Met. Psychopharmacology, 214(1),
319–328.
Eysenck, M. (1992). Anxiety: The cognitive perspective.
Hove: Lawrence Erbaum.
Figurov, A., Pozzo-Miller, L. D., Olafsson, P., Wang, T., &
Lu, B. (1996). Regulation of synaptic responses to high-
frequency stimulation and LTP by neurotrophins in the
hippocampus. Nature, 381(6584), 706–709.
Frustaci, A., Pozzi, G., Gianfagna, F., Manzoli, L., & Boccia,
S. (2008). Meta-analysis of the brain-derived neuro-
trophic factor gene (BDNF) Val66Met polymorphism
in anxiety disorders and anxiety-related personality
traits. Neuropsychobiology, 58(3–4), 163–170.
Garcia, S. E., Tully, E. C., Tarantino, N., South, S., Jacono,
W. G., & McGue, M. (2013). Changes in genetic and
environmental influences on trait anxiety from middle
adolescence to early adulthood. Journal of Affective
Disorders, 151(1), 46–53.
Gatt, J. M., Nemeroff, C. B., Dobson-Stone, C., Paul, R. H.,
Bryant, R. A., Schofield, P. R., . . . Williams, L. M. (2009).
Interactions between BDNF Val66Met polymorphism
and early life stress predict brain and arousal pathways
to syndromal depression and anxiety. Molecular
Psychiatry, 14(7), 681–695.
González, J. R., Armengol, L., Solé, X., Guinó, E., Mercader,
J. M., Estivill, X., & Moreno, V. (2007). SNPassoc: An R
package to perform whole genome association studies.
Bioinformatics, 23(5), 644–645.
Greger, H. K., Myhre, A. K., Lydersen, S., & Jozefiak, T.
(2015). Previous maltreatment and present mental
health in a high-risk adolescent population. Child
Abuse and Neglect, 45, 122–134.
Gunthert, K. C., Conner, T. S., Armeli, S., Tennen, H.,
Covault, J., & Kranzler, H. R. (2007). Serotonin trans-
porter gene polymorphism (5-HTTLPR) and anxiety
reactivity in daily life: A daily process approach to
gene-environment interaction. Psychosomatic Medicine,
69(8), 762–768.
Gutiérrez, B., Bellón, J. Á., Rivera, M., Molina, E., King, M.,
Marston, L., . . . Cervilla, J. (2015). The risk for major
depression conferred by childhood maltreatment is multi-
plied by BDNF and SERT genetic vulnerability: A replica-
tion study. Journal of Psychiatry and Neuroscience, 40(3),
187–196.
Hariri, A. R., Goldberg, T. E., Mattay, V. S., Kolachana, B.
S., Callicott, J. H., Egan, M. F., & Weinberger, D. R.
(2003). Brain-derived neurotrophic factor Val66Met
polymorphism affects human memory-related hippo-
campal activity and predicts memory performance. The
Journal of Neuroscience, 23(17), 6690–6694.
Hayward, C., Killen, J. D., Kraemer, H. C., & Taylor, C. B.
(2000, March). Predictors of panic attacks in adolescents.
Journal of the American Academy of Child and Adolescent
Psychiatry. doi:10.1097/00004583-200002000-00021
Hemmings, S. M. J., Kinnear, C. J., van der Merwe, L.,
Lochner, C., Corfield, V. A., Moolman-Smook, J. C., &
Stein, D. J. (2008). Investigating the role of the brain-
derived neurotrophic factor (BDNF) Val66Met variant
in obsessive-compulsive disorder (OCD). The World
Journal of Biological Psychiatry, 9(2), 82–85.
Hemmings, S. M. J., Martin, L. I., van der Merwe, L.,
Benecke, R., Domschke, K., & Seedat, S. (2016).
Serotonin transporter variants play a role in anxiety
sensitivity in South African adolescents. The World
Journal of Biological Psychiatry, 17(1), 66–75.
Hiio, K., Merenäkk, L., Nordquist, N., Parik, J., Oreland, L.,
Veidebaum, T., & Harro, J. (2011). Effects of serotonin
transporter promoter and BDNF Val66Met genotype on
personality traits in a population representative sample
of adolescents. Psychiatric Genetics, 21(5), 261–264.
Hishinuma, E. S., Miyamoto, R. H., Nishimura, S. T.,
Goebert, D. A., Yuen, N. Y., Makini, G. K., . . . Carlton,
B. S. (2001). Prediction of anxiety disorders using the
state–trait anxiety inventory for multiethnic adolescents.
Journal of Anxiety Disorders, 15(6), 511–533.
Hofer, M., Pagliusi, S. R., Hohn, A., Leibrock, J., & Barde,
Y.-A. (1990). Regional distribution of brain-derived neu-
rotrophic factor mRNA in the adult mouse brain. EMBO
Journal, 9(8), 2459–2464.
Hong, C. J., Liou, Y. J., & Tsai, S. J. (2012). Effects of BDNF
polymorphisms on brain function and behavior in health
and disease. Brain Research Bulletin, 88(5), 406–417.
Hosang, G. M., Shiles, C., Tansey, K. E., McGuffin, P., &
Uher, R. (2014). Interaction between stress and the BDNF
Val66Met polymorphism in depression: A systematic
review and meta-analysis. BMC Medicine, 12(1), 7.
Huang, E. J., & Reichardt, L. F. (2001). Neurotrophins:
Roles in neuronal development and function. Annual
Review of Neuroscience, 24, 677–736.
Ibarra, P., Alemany, S., Fatjó-Vilas, M., Córdova-Palomera,
A., Goldberg, X., Arias, B., . . . Fañanás, L. (2014). The
BDNF-Val66Met polymorphism modulates parental
rearing effects on adult psychiatric symptoms: A com-
munity twin-based study. European Psychiatry, 29(5),
293–300.
Irigaray, T. Q., Pacheco, J. B., Grassi-Oliveira, R., Fonseca,
R. P., de Carvalho Leite, J. C., & Kristensen, C. H.
(2013). Child maltreatment and later cognitive
8 L. MARTIN ET AL.
functioning: A systematic review. Psicologia: Reflexao E
Critica, 26(2), 376–382. Retrieved from www.scielo.br/
prc
Kaufman, J., Yang, B. Z., Douglas-Palumberi, H.,
Grasso, D., Lipschitz, D., Houshyar, S., . . .
Gelernter, J. (2006). Brain-derived neurotrophic fac-
tor-5-HTTLPR gene interactions and environmental
modifiers of depression in children. Biological
Psychiatry, 59(8), 673–680.
Keeley, M. L., & Storch, E. A. (2009). Anxiety disorders in
youth. Journal of Pediatric Nursing, 24(1), 26–40.
Kessler, R. C., McLaughlin, K. A., Green, J. G., Gruber, M.
J., Sampson, N. A., Zaslavsky, A. M., . . . Williams, D. R.
(2010). Childhood adversities and adult psychopathol-
ogy in the WHO world mental health surveys. British
Journal of Psychiatry, 197(5), 378–385.
Kim, S. J., Cho, S. J., Jang, H. M., Shin, J., Park, P. W., Lee,
Y. J., . . . Lee, H. J. (2009). Interaction between brain-
derived neurotrophic factor Val66Met polymorphism
and recent negative stressor in harm avoidance.
Neuropsychobiology, 61(1), 19–26.
Klauke, B., Deckert, J., Reif, A., Pauli, P., Zwanzger, P.,
Baumann, C., . . . Domschke, K. (2011). Serotonin trans-
porter gene and childhood trauma - A G × E effect on
anxiety sensitivity. Depression and Anxiety, 28(12),
1048–1057.
Lam, P., Cheng, C.-Y., Hong, C. J., & Tsai, S.-J. (2004).
Association study of a brain-derived neurotrophic factor
(Val66Met) genetic polymorphism and panic disorder.
Neuropsychobiology, 49(4), 178–181.
Lang, U. E., Hellweg, R., Kalus, P., Bajbouj, M., Lenzen, K.
P., Sander, T., . . . Gallinat, J. (2005). Association of a
functional BDNF polymorphism and anxiety-related
personality traits. Psychopharmacology, 180(1), 95–99.
Lau, J. Y. F., Gregory, A.M., Goldwin,M.A., Pine, D. S., & Eley,
T. (2007). Assessing gene-environment interactions on anxi-
ety symptom subtypes across childhood and adolescence.
Development and Psychopathology, 19(4), 1129–1146.
Laucht, M., Treutlein, J., Blomeyer, D., Buchmann, A. F.,
Schmid, B., Becker, K., . . . Banaschewski, T. (2009).
Interaction between the 5-HTTLPR serotonin transpor-
ter polymorphism and environmental adversity for
mood and anxiety psychopathology: Evidence from a
high-risk community sample of young adults. The
International Journal of Neuropsychopharmacology, 12
(6), 737–747.
Lehto, K., Maestu, J., Kiive, E., Veidebaum, T., & Harro, J.
(2016). BDNF Val66Met genotype and neuroticism pre-
dict life stress: A longitudinal study from childhood to
adulthood. European Neuropsychopharmacology, 26(3),
562–569.
Li, M., Chang, H., & Xiao, X. (2016). BDNF Val66Met
polymorphism and bipolar disorder in European popu-
lations: A risk association in case-control, family-based
and GWAS studies. Neuroscience & Biobehavioral
Reviews, 68, 218–233.
Mandelman, S. D., & Grigorenko, E. L. (2012). BDNF
Val66Met and cognition: All, none, or some? A meta-
analysis of the genetic association. Genes, Brain and
Behavior, 11(2), 127–136.
Martin, L, Viljoen, M, Kidd, M, & Seedat, S. (2014). Are
Childhood Trauma Exposures Predictive Of Anxiety
Sensitivity in School Attending Youth? Journal Of
Affective Disorders, 168, 5-12.
Martinowich, K., & Lu, B. (2008). Interaction between
BDNF and serotonin: Role in mood disorders.
Neuropsychopharmacology, 33(1), 73–83.
Martinowich, K., Manji, H., & Lu, B. (2007). New insights
into BDNF function in depression and anxiety. Nature
Neuroscience, 10(9), 1089–1093.
McLaughlin, E. N., Stewart, S. H., & Taylor, S. (2007).
Childhood anxiety sensitivity index factors predict
unique variance in DSM-IV anxiety disorder symptoms.
Cognitive Behaviour Therapy, 36(4), 210–219.
McLaughlin, K. A., Green, J. G., Gruber, M. J., Sampson, N.
A., Zaslavsky, A. M., & Kessler, R. C. (2012). Childhood
adversities and first onset of psychiatric disorders in a
national sample of US adolescents. JAMA Psychiatry, 69
(11), 1151–1160. Retrieved from http://libezproxy.open.
ac.uk/login?url=http://search.ebscohost.com/login.aspx?
direct=true&db=psyh&AN=2013-03085-007&site=
ehost-live&scope=site&scope=cite
McLaughlin, K. A., & Hatzenbuehler, M. L. (2009).
Stressful life events, anxiety sensitivity, and internalizing
symptoms in adolescents. Journal of Abnormal
Psychology, 118(3), 659–669.
Min, J. A., Lee, H. J., Lee, S. H., Park, Y. M., Kang, S. G., &
Chae, J. H. (2013). Gender-specific effects of brain-derived
neurotrophic factor Val66Met polymorphism and child-
hood maltreatment on anxiety. Neuropsychobiology, 67(1),
6–13.
Minelli, A., Zanardini, R., Bonvicini, C., Sartori, R., Pedrini,
L., Gennarelli, M., & Bocchio-Chiavetto, L. (2011). BDNF
serum levels, but not BDNF Val66Met genotype, are cor-
related with personality traits in healthy subjects. European
Archives of Psychiatry and Clinical Neuroscience, 261(5),
323–329.
Mitoma, M., Yoshimura, R., Sugita, A., Umene, W., Hori,
H., Nakano, H., . . . Nakamura, J. (2008). Stress at work
alters serum brain-derived neurotrophic factor (BDNF)
levels and plasma 3-methoxy-4-hydroxyphenylglycol
(MHPG) levels in healthy volunteers: BDNF and
MHPG as possible biological markers of mental stress?
Progress in Neuro-Psychopharmacology and Biological
Psychiatry, 32(3), 679–685.
Molendijk, M. L., Spinhoven, P., Polak, M., Bus, B. A. A.,
Penninx, B. W. J. H., & Elzinga, B. M. (2014). Serum
BDNF concentrations as peripheral manifestations of
depression: Evidence from a systematic review and
meta-analyses on 179 associations (N=9484). Molecular
Psychiatry, 19(7), 791–800.
Montag, C., Basten, U., Stelzel, C., Fiebach, C. J., & Reuter,
M. (2010). The BDNF Val66Met polymorphism and
anxiety: Support for animal knock-in studies from a
genetic association study in humans. Psychiatry
Research, 179(1), 86–90.
Murakami, S., Imbe, H., Morikawa, Y., Kubo, C., & Senba,
E. (2005). Chronic stress, as well as acute stress, reduces
BDNF mRNA expression in the rat hippocampus but
less robustly. Neuroscience Research, 53(2), 129–139.
Muris, P., Schmidt, H., Merckelbach, H., & Schouten, E.
(2001). Anxiety sensitivity in adolescents: Factor struc-
ture and relationships to trait anxiety and symptoms of
anxiety disorders and depression. Behaviour Research
and Therapy, 39(1), 89–100. Retrieved from http://
www.ncbi.nlm.nih.gov/pubmed/11125726
Nedic, G., Nikolac Perkovic, M., Nenadic Sviglin, K.,
Muck-Seler, D., Borovecki, F., & Pivac, N. (2013).
Brain-derived neurotrophic factor Val66Met poly-
morphism and alcohol-related phenotypes. Progress in
Neuro-Psychopharmacology and Biological Psychiatry, 40
(1), 193–198.
Nordanger, D. O., Breivik, K., Haugland, B. S., Lehman, S.,
Mæhle, M., Braarud, H. C., & Hysing, M. (2014). Prior
EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY 9
adversities predict posttraumatic stress reactions in ado-
lescents following the Oslo Terror events 2011. European
Journal of Psychotraumatology, 5, 23159.
Notaras, M., Hill, R., & van den Buuse, M. (2015). The
BDNF gene Val66Met polymorphism as a modifier of
psychiatric disorder susceptibility: Progress and contro-
versy. Molecular Psychiatry, 20(8), 916–930.
Petryshen, T. L., Sabeti, P. C., Aldinger, K. A., Fry, B., Fan,
J. B., Schaffner, S. F., . . . Sklar, P. (2009). Population
genetic study of the brain-derived neurotrophic factor
(BDNF) gene. Molecular Psychiatry, 15(8), 1–6.
Pezawas, L., Meyer-Lindenberg, A., Goldman, A. L.,
Verchinski, B. A., Chen, G., Kolachana, B. S., . . .
Weinberger, D. R. (2008). Evidence of biologic epistasis
between BDNF and SLC6A4 and implications for
depression. Molecular Psychiatry, 13(7), 709–716.
Pivac, N., Kim, B., Nedić, G., Joo, Y. H., Kozarić-Kovacić,
D., Hong, J. P., & Muck-Seler, D. (2009). Ethnic differ-
ences in brain-derived neurotrophic factor Val66Met
polymorphism in Croatian and Korean healthy partici-
pants. Croatian Medical Journal, 50(1), 43–48.
Reiss, S., & McNally, R. (1985). Expectancy model of fear.
In S. Reiss & R. R. Bootzin (Eds.), Theoretical issues in
behavior therapy (pp. 107–121). San Diego, CA:
Academic Press.
Reiss, S., Peterson, R. A., Gursky, D. M., & McNally, R. J.
(1986). Anxiety sensitivity, anxiety frequency and the
prediction of fearfulness. Behaviour Research and
Therapy, 24(1), 1–8. Retrieved from http://www.ncbi.
nlm.nih.gov/pubmed/3947307
Scher, C. D., & Stein, M. B. (2003). Developmental ante-
cedents of anxiety sensitivity. Journal of Anxiety
Disorders, 17(3), 253–269. Retrieved from http://www.
ncbi.nlm.nih.gov/pubmed/12727121
Schiele, M. A., Ziegler, C., Holitschke, K., Schartner, C.,
Schmidt, B., Weber, H., . . . Domschke, K. (2016).
Influence of 5-HTT variation, childhood trauma and
self-efficacy on anxiety traits: A gene-environment-cop-
ing interaction study. Journal of Neural Transmission,
123(8), 895–904.
Schmidt, N., Zvolensky, M., & Maner, J. (2006). Anxiety
sensitivity: Prospective prediction of panic attacks and
Axis I pathology. Journal of Psychiatric Research, 40(8),
691–699.
Schmidt, N. B., Keough, M. E., Mitchell, M. A., Reynolds,
E. K., Macpherson, L., Zvolensky, M. J., & Lejuez, C. W.
(2010). Anxiety sensitivity: Prospective prediction of
anxiety among early adolescents. Journal of Anxiety
Disorders, 24(5), 503–508.
Sen, S., Nesse, R. M., Stoltenberg, S. F., Li, S., Gleiberman,
L., Chakravarti, A., . . . Burmeister, M. (2003). A BDNF
coding variant is associated with the NEO personality
inventory domain neuroticism, a risk factor for depres-
sion. Neuropsychopharmacology, 28(2), 397–401.
Silverman, W. K, Fleisig, W, Rabian, B, & Peterson, R. A.
(1991). Childhood anxiety sensitivity index. Journal of
Clinical Child and adolescent Psychology, 20(2), 162–168.
doi:
Simmons, A., Strigo, I., Matthews, S. C., Paulus, M. P., &
Stein, M. B. (2006). Anticipation of aversive visual sti-
muli is associated with increased insula activation in
anxiety-prone subjects. Biological Psychiatry, 60(4),
402–409.
Şimşek, Ş., Yüksel, T., Kaplan, I., Uysal, C., & Alaca, R. (2015).
Examining the levels of BDNF and cortisol in children and
adolescent victims of sexual abuse - a preliminary study.
Comprehensive Psychiatry, 61(2015), 23–27.
StatSoftInc. (2015). STATISTICA version 13. Tulsa, OK:
StatSoftInc.
Stein, M. B., Jang, K. L., & Livesley, W. J. (1999).
Heritability of anxiety sensitivity: A twin study. The
American Journal of Psychiatry, 156(2), 246–251.
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/
9989561
Stein, M. B., Schork, N. J., & Gelernter, J. (2008). Gene-by-
environment (serotonin transporter and childhood mal-
treatment) interaction for anxiety sensitivity, an inter-
mediate phenotype for anxiety disorders.
Neuropsychopharmacology, 33(2), 312–319.
Suliman, S., Hemmings, S. M. J., & Seedat, S. (2013). Brain-
derived neurotrophic factor (BDNF) protein levels in
anxiety disorders: Systematic review and meta-regres-
sion analysis. Frontiers in Integrative Neuroscience, 7
(July), 55.
Surtees, P., Wainwright, N., Willis-Owen, S., Sandhu,
M., Luben, R., Day, N., & Flint, J. (2007). No asso-
ciation between the BDNF Val66Met polymorphism
and mood status in a non-clinical community sample
of 7389 older adults. Journal of Psychiatric Research,
41(5), 404–409.
Suzuki, G., Tokuno, S., Nibuya, M., Ishida, T., Yamamoto,
T., Mukai, Y., . . . Shimizu, K. (2014). Decreased plasma
brain-derived neurotrophic factor and vascular endothe-
lial growth factor concentrations during military train-
ing. PLoS ONE, 9(2), 1–9.
Szentágotai-Tətar, A., Chis, A., Vulturar, R., Dobrean, A.,
Cândea, D. M., & Miu, A. C. (2015). Shame and guilt-
proneness in adolescents: Gene-environment interac-
tions. PLoS One, 10(7), 1–16.
Taillieu, T. L., Brownridge, D. A., Sareen, J., & Afifi, T. O.
(2016). Childhood emotional maltreatment and mental
disorders: Results from a nationally representative adult
sample from the United States. Child Abuse and Neglect,
59, 1–12.
Teicher, M., Ohashi, K., Lowen, S., Polcari, A., &
Fitzmaurice, G. (2015). Mood dysregulation and affec-
tive instability in emerging adults with childhood mal-
treatment: An ecological momentary assessment study.
Journal of Psychiatric Research, 70, 1–8.
Terracciano, A., Tanaka, T., Sutin, A. R., Deiana, B., Balaci,
L., Sanna, S., . . . Costa, P. T. (2010). BDNF Val66Met is
associated with introversion and interacts with 5-
HTTLPR to influence neuroticism.
Neuropsychopharmacology, 35(5), 1083–1089.
Tishkoff, S. A., Reed, F. A., Friedlaender, F. R., Ranciaro,
A., Froment, A., Hirbo, J. B., . . . Williams, S. M. (2009).
The genetic structure and history of Africans and
African Americans. Science, 324(5930), 1035–1044.
Tocchetto, A., Salum, G. A., Blaya, C., Teche, S., Isolan, L.,
Bortoluzzi, A., . . . Manfro, G. G. (2011). Evidence of
association between Val66Met polymorphism at BDNF
gene and anxiety disorders in a community sample of
children and adolescents. Neuroscience Letters, 502(3),
197–200.
Tollenaar, M. S., Molendijk, M. L., Penninx, B. W. J. H.,
Milaneschi, Y., & Antypa, N. (2017). The association of
childhood maltreatment with depression and anxiety is
not moderated by the oxytocin receptor gene. European
Archives of Psychiatry and Clinical Neurosciences, 267,
517–526.
Vendlinski, M. K., Lemery-Chalfant, K., Essex, M. J., &
Goldsmith, H. H. (2011). Genetic risk by experience
interaction for childhood internalizing problems:
Converging evidence across multiple methods. Journal
10 L. MARTIN ET AL.
of Child Psychology and Psychiatry and Allied Disciplines,
52(5), 607–618.
Wang, Y., Zhang, H., Li, Y., Wang, Z., Fan, Q., Yu, S.,
. . . Xiao, Z. (2015). BDNF Val66Met polymorphism
and plasma levels in Chinese Han population with
obsessive-compulsive disorder and generalized anxi-
ety disorder. Journal of Affective Disorders, 186(2015),
7–12.
Weems, C. F., Pina, A. A., Costa, N. M., Watts, S. E.,
Taylor, L. K., & Cannon, M. F. (2007). Predisaster trait
anxiety and negative affect predict posttraumatic stress
in youths after hurricane Katrina. Journal of Consulting
and Clinical Psychology, 75(1), 154–159.
Weems, C. F., & Stickle, T. R. (2005). Anxiety disorders in
childhood: Casting a nomological net. Clinical Child and
Family Psychology Review, 8(2), 107–134.
Willis-Owen, S. A. G., Fullerton, J., Surtees, P. G.,
Wainwright, N. W. J., Miller, S., & Flint, J. (2005). The
Val66Met coding variant of the brain-derived neuro-
trophic factor (BDNF) gene does not contribute toward
variation in the personality trait neuroticism. Biological
Psychiatry, 58(9), 738–742.
Wright, G. E., Niehaus, D. J., Koen, L., Drögemöller, B. I.,
& Warnich, L. (2011). Psychiatric genetics in South
Africa: Cutting a rough diamond. African Journal of
Psychiatry, 14(5), 355–366.
Yamada, K., Mizuno, M., & Nabeshima, T. (2002). Role for
brain-derived neurotrophic factor in learning and mem-
ory. Life Sciences, 70(7), 735–744.
Zavos, H. M. S., Gregory, A. M., & Eley, T. C. (2012).
Longitudinal genetic analysis of anxiety sensitivity.
Developmental Psychology, 48(1), 204–212.
Zavos, H. M. S., Rijsdijk, F. V., & Eley, T. C. (2012). A
longitudinal, genetically informative, study of associa-
tions between anxiety sensitivity, anxiety and depression.
Behavior Genetics, 42(4), 592–602.
Zavos, H. M. S., Rijsdijk, F. V., Gregory, A. M., & Eley, T.
C. (2010). Genetic influences on the cognitive biases
associated with anxiety and depression symptoms in
adolescents. Journal of Affective Disorders, 124(1–2),
45–53.
Zavos, H. M. S., Wong, C. C. Y., Barclay, N. L., Keers, R.,
Mill, J., Rijsdijk, F. V., . . . Eley, T. C. (2012). Anxiety
sensitivity in adolescence and young adulthood: The role
of stressful life events, 5HTTLPR and their interaction.
Depression and Anxiety, 29(5), 400–408.
Zeni, C. P., Tramontina, S., Zeni, T. A., Coelho, R., Pheula,
G., Bernardi, J., . . . Rohde, L. A. (2013). The Val66Met
polymorphism at the BDNF gene does not influence
Wisconsin Card Sorting test results in children and
adolescents with bipolar disorder. Revista Brasileira De
Psiquiatria, 35(1), 44–50.
EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY 11
